Aoki M et al. |
Expression of BMP-7 in human gastric cancer and its clinical significance. |
2011 |
Br. J. Cancer |
pmid:21224856
|
Maeda S et al. |
Clinical significance of midkine expression in pancreatic head carcinoma. |
2007 |
Br. J. Cancer |
pmid:17622248
|
Kim TJ et al. |
Increased expression of pAKT is associated with radiation resistance in cervical cancer. |
2006 |
Br. J. Cancer |
pmid:16721365
|
Ichikawa W et al. |
Thymidylate synthase predictive power is overcome by irinotecan combination therapy with S-1 for gastric cancer. |
2004 |
Br. J. Cancer |
pmid:15354215
|
Kawaguchi Y et al. |
Targeting EGFR and HER-2 with cetuximab- and trastuzumab-mediated immunotherapy in oesophageal squamous cell carcinoma. |
2007 |
Br. J. Cancer |
pmid:17622245
|
Jamerson MH et al. |
Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice. |
2004 |
Br. J. Cancer |
pmid:15354213
|
Liu WM et al. |
Inhibition of metastatic potential in colorectal carcinoma in vivo and in vitro using immunomodulatory drugs (IMiDs). |
2009 |
Br. J. Cancer |
pmid:19638977
|
Couvelard A et al. |
Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. |
2005 |
Br. J. Cancer |
pmid:15558070
|
Kupryjańczyk J et al. |
TP53 status determines clinical significance of ERBB2 expression in ovarian cancer. |
2004 |
Br. J. Cancer |
pmid:15545967
|
Alì G et al. |
Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact. |
2009 |
Br. J. Cancer |
pmid:19935800
|
Brownhill SC et al. |
Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT. |
2007 |
Br. J. Cancer |
pmid:17533400
|
Lorch G et al. |
Inhibition of epidermal growth factor receptor signalling reduces hypercalcaemia induced by human lung squamous-cell carcinoma in athymic mice. |
2007 |
Br. J. Cancer |
pmid:17533397
|
Buggy Y et al. |
Overexpression of the Ets-1 transcription factor in human breast cancer. |
2004 |
Br. J. Cancer |
pmid:15365563
|
Unoki M et al. |
UHRF1 is a novel diagnostic marker of lung cancer. |
2010 |
Br. J. Cancer |
pmid:20517312
|
Caldwell GM et al. |
Reorganisation of Wnt-response pathways in colorectal tumorigenesis. |
2008 |
Br. J. Cancer |
pmid:18414471
|
Bridgewater J et al. |
Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary. |
2008 |
Br. J. Cancer |
pmid:18414470
|
Aoyagi Y et al. |
Overexpression of TGF-beta by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer. |
2004 |
Br. J. Cancer |
pmid:15365564
|
Legrier ME et al. |
Potentiation of antitumour activity of docetaxel by combination with trastuzumab in a human prostate cancer xenograft model and underlying mechanisms. |
2007 |
Br. J. Cancer |
pmid:17211467
|
Tajima Y et al. |
Gastric and intestinal phenotypic marker expression in gastric carcinomas and recurrence pattern after surgery-immunohistochemical analysis of 213 lesions. |
2004 |
Br. J. Cancer |
pmid:15354218
|
Darby S et al. |
Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease. |
2009 |
Br. J. Cancer |
pmid:19888221
|
Li Q et al. |
Expression of interferon-gamma in human adrenal gland and kidney tumours. |
2007 |
Br. J. Cancer |
pmid:17622250
|
Köhler S et al. |
E-/P-selectins and colon carcinoma metastasis: first in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lung. |
2010 |
Br. J. Cancer |
pmid:20010946
|
Takano T et al. |
BRAF V600E mutation in anaplastic thyroid carcinomas and their accompanying differentiated carcinomas. |
2007 |
Br. J. Cancer |
pmid:17453004
|
Grunewald TG et al. |
Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation. |
2007 |
Br. J. Cancer |
pmid:17211471
|
Fareed KR et al. |
Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy. |
2010 |
Br. J. Cancer |
pmid:20461087
|
Frietsch JJ et al. |
Nuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer. |
2010 |
Br. J. Cancer |
pmid:20461080
|
Bruland O et al. |
Gene expression reveals two distinct groups of anal carcinomas with clinical implications. |
2008 |
Br. J. Cancer |
pmid:18349847
|
Yoshioka T et al. |
Infiltrating regulatory T cell numbers is not a factor to predict patient's survival in oesophageal squamous cell carcinoma. |
2008 |
Br. J. Cancer |
pmid:18349839
|
Maeda S et al. |
CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer. |
2008 |
Br. J. Cancer |
pmid:18349830
|
Sakamoto A et al. |
Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor gamma in epithelial ovarian tumours. |
2004 |
Br. J. Cancer |
pmid:15266333
|
McArdle PA et al. |
The relationship between T-lymphocyte subset infiltration and survival in patients with prostate cancer. |
2004 |
Br. J. Cancer |
pmid:15266325
|
Park SW et al. |
Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma. |
2004 |
Br. J. Cancer |
pmid:15266310
|
Mukherjee R et al. |
Upregulation of MAPK pathway is associated with survival in castrate-resistant prostate cancer. |
2011 |
Br. J. Cancer |
pmid:21559022
|
Elsir T et al. |
PROX1 is a predictor of survival for gliomas WHO grade II. |
2011 |
Br. J. Cancer |
pmid:21559010
|
Comstock CE et al. |
Impact of differential cyclin D1 expression and localisation in prostate cancer. |
2007 |
Br. J. Cancer |
pmid:17375037
|
Went P et al. |
Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. |
2006 |
Br. J. Cancer |
pmid:16404366
|
Bingle L et al. |
Macrophages promote angiogenesis in human breast tumour spheroids in vivo. |
2006 |
Br. J. Cancer |
pmid:16404363
|
Angst E et al. |
Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer. |
2006 |
Br. J. Cancer |
pmid:16832411
|
Varey AH et al. |
VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. |
2008 |
Br. J. Cancer |
pmid:18349829
|
Woodhams JH et al. |
Correlation of real-time haemoglobin oxygen saturation monitoring during photodynamic therapy with microvascular effects and tissue necrosis in normal rat liver. |
2004 |
Br. J. Cancer |
pmid:15266317
|
Ameri K et al. |
Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype. |
2010 |
Br. J. Cancer |
pmid:20051957
|
Akahira JI et al. |
Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer. |
2004 |
Br. J. Cancer |
pmid:15164121
|
Gisselsson D et al. |
Telomere shortening and mitotic dysfunction generate cytogenetic heterogeneity in a subgroup of renal cell carcinomas. |
2004 |
Br. J. Cancer |
pmid:15162157
|
Pazgal I et al. |
Expression of basic fibroblast growth factor is associated with poor outcome in non-Hodgkin's lymphoma. |
2002 |
Br. J. Cancer |
pmid:12087465
|
van't Land B et al. |
Transforming Growth Factor-beta2 protects the small intestine during methotrexate treatment in rats possibly by reducing stem cell cycling. |
2002 |
Br. J. Cancer |
pmid:12085266
|
Hall GH et al. |
Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours. |
2002 |
Br. J. Cancer |
pmid:12085262
|
Chakraborty S et al. |
Constitutive androstane receptor agonist CITCO inhibits growth and expansion of brain tumour stem cells. |
2011 |
Br. J. Cancer |
pmid:21224854
|
Bhagavathula N et al. |
Upregulation of calcium-sensing receptor and mitogen-activated protein kinase signalling in the regulation of growth and differentiation in colon carcinoma. |
2005 |
Br. J. Cancer |
pmid:16278666
|
Chou SC et al. |
Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomas. |
2004 |
Br. J. Cancer |
pmid:14760391
|
Olivier RI et al. |
Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up. |
2004 |
Br. J. Cancer |
pmid:15083174
|
Shinto O et al. |
Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells. |
2010 |
Br. J. Cancer |
pmid:20145621
|
Stessels F et al. |
Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia. |
2004 |
Br. J. Cancer |
pmid:15054467
|
Yao M et al. |
Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer. |
2004 |
Br. J. Cancer |
pmid:14760389
|
de Plater L et al. |
Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation. |
2010 |
Br. J. Cancer |
pmid:20877358
|
Mah-Becherel MC et al. |
Anti-angiogenic effects of the thienopyridine SR 25989 in vitro and in vivo in a murine pulmonary metastasis model. |
2002 |
Br. J. Cancer |
pmid:11875746
|
Kamoshida S et al. |
Immunostaining of thymidylate synthase and p53 for predicting chemoresistance to S-1/cisplatin in gastric cancer. |
2007 |
Br. J. Cancer |
pmid:17211470
|
Montagut C et al. |
Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patients. |
2010 |
Br. J. Cancer |
pmid:20234366
|
Kameda C et al. |
Oestrogen receptor-alpha contributes to the regulation of the hedgehog signalling pathway in ERalpha-positive gastric cancer. |
2010 |
Br. J. Cancer |
pmid:20087349
|
Weigelt B et al. |
No common denominator for breast cancer lymph node metastasis. |
2005 |
Br. J. Cancer |
pmid:16189523
|
Van Valckenborgh E et al. |
Murine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo. |
2002 |
Br. J. Cancer |
pmid:11875745
|
Schrader C et al. |
Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma. |
2005 |
Br. J. Cancer |
pmid:16189522
|
Shields JD et al. |
Lymphatic density and metastatic spread in human malignant melanoma. |
2004 |
Br. J. Cancer |
pmid:14760386
|
Almstrup K et al. |
Carcinoma in situ testis displays permissive chromatin modifications similar to immature foetal germ cells. |
2010 |
Br. J. Cancer |
pmid:20823885
|
Hamaguchi T et al. |
NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel. |
2005 |
Br. J. Cancer |
pmid:15785749
|
Koga F et al. |
Impaired Delta Np63 expression associates with reduced beta-catenin and aggressive phenotypes of urothelial neoplasms. |
2003 |
Br. J. Cancer |
pmid:12618884
|
Franc B et al. |
Histological validation of diagnoses of thyroid cancer among adults in the registries of Belarus and the Ukraine. |
2003 |
Br. J. Cancer |
pmid:14647144
|
Murri AM et al. |
The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer. |
2008 |
Br. J. Cancer |
pmid:18797461
|
Tabori U et al. |
Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma. |
2008 |
Br. J. Cancer |
pmid:18797459
|
Verschoyle RD et al. |
Evaluation of the cancer chemopreventive efficacy of rice bran in genetic mouse models of breast, prostate and intestinal carcinogenesis. |
2007 |
Br. J. Cancer |
pmid:17211473
|
Wang EL et al. |
High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer. |
2010 |
Br. J. Cancer |
pmid:20145615
|
Farooqui M et al. |
COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. |
2007 |
Br. J. Cancer |
pmid:17971769
|
Cellai C et al. |
Growth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086. |
2006 |
Br. J. Cancer |
pmid:16721373
|
Yamamoto E et al. |
Expression of N-acetylglucosaminyltransferase V in endometrial cancer correlates with poor prognosis. |
2007 |
Br. J. Cancer |
pmid:17971775
|
Hagiwara S et al. |
Combination therapy with PEG-IFN-alpha and 5-FU inhibits HepG2 tumour cell growth in nude mice by apoptosis of p53. |
2007 |
Br. J. Cancer |
pmid:17971768
|
Prencipe M et al. |
Cellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitro. |
2009 |
Br. J. Cancer |
pmid:19935801
|
Nomoto S et al. |
Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma. |
2007 |
Br. J. Cancer |
pmid:17968429
|
Houston A et al. |
Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-beta expression. |
2003 |
Br. J. Cancer |
pmid:14520470
|
Hori K and Saito S |
Microvascular mechanisms by which the combretastatin A-4 derivative AC7700 (AVE8062) induces tumour blood flow stasis. |
2003 |
Br. J. Cancer |
pmid:14520469
|
Al-Attar A et al. |
Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers. |
2010 |
Br. J. Cancer |
pmid:20087352
|
Jeon TY et al. |
Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells. |
2010 |
Br. J. Cancer |
pmid:20087351
|
Geoerger B et al. |
Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts. |
2003 |
Br. J. Cancer |
pmid:12888833
|
Shuyama K et al. |
Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China. |
2007 |
Br. J. Cancer |
pmid:17453003
|
Nosho K et al. |
Gene expression profiling of colorectal adenomas and early invasive carcinomas by cDNA array analysis. |
2005 |
Br. J. Cancer |
pmid:15785755
|
Santin AD et al. |
Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy. |
2005 |
Br. J. Cancer |
pmid:15785748
|
Mimori K et al. |
Reduced tau expression in gastric cancer can identify candidates for successful Paclitaxel treatment. |
2006 |
Br. J. Cancer |
pmid:16721363
|
Arrieta O et al. |
Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma. |
2005 |
Br. J. Cancer |
pmid:15785746
|
Nakase Y et al. |
Frequent loss of RUNX3 gene expression in remnant stomach cancer and adjacent mucosa with special reference to topography. |
2005 |
Br. J. Cancer |
pmid:15685235
|
Dive C et al. |
Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer. |
2010 |
Br. J. Cancer |
pmid:20051949
|
Alazawi W et al. |
Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions: associations with lesion grade, state of the HPV16 E2 gene and clinical outcome. |
2004 |
Br. J. Cancer |
pmid:15545968
|
Radke I et al. |
Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer. |
2006 |
Br. J. Cancer |
pmid:16832410
|
Chatrath P et al. |
Immunohistochemical estimation of cell cycle phase in laryngeal neoplasia. |
2006 |
Br. J. Cancer |
pmid:16832409
|
Nomura H et al. |
Network-based analysis of calcium-binding protein genes identifies Grp94 as a target in human oral carcinogenesis. |
2007 |
Br. J. Cancer |
pmid:17726464
|
Horii R et al. |
Optimal indications of endocrine therapy alone as adjuvant systemic treatment of breast cancer. |
2007 |
Br. J. Cancer |
pmid:17726451
|
Yu J et al. |
Increased expression of survivin in gastric cancer patients and in first degree relatives. |
2002 |
Br. J. Cancer |
pmid:12085263
|
McCarty MF et al. |
ZD6126 inhibits orthotopic growth and peritoneal carcinomatosis in a mouse model of human gastric cancer. |
2004 |
Br. J. Cancer |
pmid:14760388
|
Gaya A et al. |
Relationship between human tumour angiogenic profile and combretastatin-induced vascular shutdown: an exploratory study. |
2008 |
Br. J. Cancer |
pmid:18612312
|
Manton KJ et al. |
Hypermethylation of the 5' CpG island of the gene encoding the serine protease Testisin promotes its loss in testicular tumorigenesis. |
2005 |
Br. J. Cancer |
pmid:15685234
|
Tonetti DA et al. |
Elevated protein kinase C alpha expression may be predictive of tamoxifen treatment failure. |
2003 |
Br. J. Cancer |
pmid:12778068
|
Marotta A et al. |
Characterisation of integrin-linked kinase signalling in sporadic human colon cancer. |
2003 |
Br. J. Cancer |
pmid:12771992
|
Nalwoga H et al. |
Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer. |
2010 |
Br. J. Cancer |
pmid:20010944
|